PONZ DE LEON, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.341
AS - Asia 18.599
EU - Europa 16.531
SA - Sud America 2.564
AF - Africa 331
Continente sconosciuto - Info sul continente non disponibili 284
OC - Oceania 31
Totale 82.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.690
GB - Regno Unito 7.282
SG - Singapore 6.182
CN - Cina 5.131
HK - Hong Kong 2.074
BR - Brasile 1.985
IT - Italia 1.772
VN - Vietnam 1.682
SE - Svezia 1.553
DE - Germania 1.437
UA - Ucraina 1.093
FI - Finlandia 981
TR - Turchia 876
BD - Bangladesh 754
RU - Federazione Russa 665
FR - Francia 623
KR - Corea 494
BG - Bulgaria 390
IN - India 352
CA - Canada 321
AR - Argentina 203
ID - Indonesia 156
MX - Messico 151
IQ - Iraq 146
NL - Olanda 128
JP - Giappone 117
EC - Ecuador 100
ZA - Sudafrica 98
IE - Irlanda 86
PK - Pakistan 84
BE - Belgio 83
ES - Italia 79
CO - Colombia 77
AE - Emirati Arabi Uniti 73
PL - Polonia 64
VE - Venezuela 60
CL - Cile 59
MY - Malesia 56
UZ - Uzbekistan 45
SA - Arabia Saudita 44
AT - Austria 42
PH - Filippine 41
MA - Marocco 39
JM - Giamaica 38
NP - Nepal 36
RO - Romania 34
LT - Lituania 33
TN - Tunisia 33
CR - Costa Rica 32
EG - Egitto 32
KE - Kenya 30
DZ - Algeria 29
CZ - Repubblica Ceca 28
JO - Giordania 28
PY - Paraguay 28
TH - Thailandia 28
AZ - Azerbaigian 27
AU - Australia 24
TW - Taiwan 23
IL - Israele 20
PE - Perù 20
PT - Portogallo 17
OM - Oman 16
CH - Svizzera 15
IR - Iran 15
KZ - Kazakistan 15
TT - Trinidad e Tobago 14
UY - Uruguay 14
AL - Albania 13
BO - Bolivia 13
DO - Repubblica Dominicana 13
BY - Bielorussia 12
DK - Danimarca 12
ET - Etiopia 11
EU - Europa 11
NI - Nicaragua 11
PR - Porto Rico 11
RS - Serbia 11
SY - Repubblica araba siriana 11
GE - Georgia 10
GR - Grecia 10
GT - Guatemala 9
LB - Libano 9
MD - Moldavia 9
PS - Palestinian Territory 9
BZ - Belize 8
HN - Honduras 8
HR - Croazia 8
PA - Panama 8
SN - Senegal 8
HU - Ungheria 7
KG - Kirghizistan 7
KW - Kuwait 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
BB - Barbados 6
LK - Sri Lanka 6
NG - Nigeria 6
Totale 82.288
Salva come PNG Salva come JPEG
Città #
Southend 5.521
Singapore 4.119
Ashburn 3.583
Fairfield 3.408
Santa Clara 3.352
Woodbridge 2.653
Houston 2.229
Jacksonville 2.224
Hong Kong 2.050
Chandler 1.835
Hefei 1.744
San Jose 1.639
Dearborn 1.427
Ann Arbor 1.336
Wilmington 1.324
Seattle 1.299
Chicago 1.291
Cambridge 1.116
Los Angeles 987
Beijing 923
Nyköping 895
London 864
Council Bluffs 767
Helsinki 579
The Dalles 548
Salt Lake City 545
Ho Chi Minh City 514
Princeton 487
Izmir 463
Seoul 452
Hanoi 409
Sofia 380
Modena 372
Eugene 367
New York 366
San Diego 362
Lauterbourg 299
Des Moines 289
Buffalo 279
Dallas 263
Milan 259
Elk Grove Village 255
Boardman 254
Columbus 246
Tampa 241
Moscow 226
Shanghai 194
São Paulo 161
Sterling 138
Frankfurt am Main 137
Lancaster 127
Phoenix 126
Bremen 114
Munich 113
Miami 109
Grafing 101
Falls Church 99
Orem 94
Tokyo 93
Atlanta 88
Da Nang 88
Jakarta 79
Guangzhou 72
Detroit 71
Rome 67
Dulles 66
Mexico City 64
Norwalk 63
Brussels 62
Haiphong 62
Rio de Janeiro 62
Dublin 61
Toronto 60
Falkenstein 58
Brooklyn 57
Fremont 57
Baghdad 56
Kunming 56
Chennai 55
Nanjing 54
Montreal 53
Miano 51
Pittsburgh 51
Belo Horizonte 50
Rochester 50
Denver 49
Philadelphia 49
Kansas City 48
Kent 48
North Bergen 48
Quito 46
Reading 44
San Francisco 44
Charlotte 43
Cardiff 42
Dhaka 42
Naples 41
Boston 40
Tashkent 40
Turku 40
Totale 58.924
Salva come PNG Salva come JPEG
Nome #
Estimates of cancer burden in Italy 717
Surgical management of the duodenal manifestations of familial adenomatous polyposis 544
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 509
Attenuated polyposis of the large bowel: a morphologic and molecular approach 474
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 462
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 460
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 453
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 441
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 439
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 438
Lymph node micrometastasis and survival of patients with Stage i (Dukes' A) colorectal carcinoma 432
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 427
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 421
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 417
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 415
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis 415
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 404
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 401
An unusual case of familial adenomatous polyposis with very early symptom occurrence 400
K-ras and p53 mutations in human colorectal aberrant crypt foci 399
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 398
Microsatellite instability in multiple colorectal tumors 394
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 394
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 391
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 389
Aetiology of colorectal cancer and relevance of monogenic inheritance. 386
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 385
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 382
The influence of age on colonic epithelial cell proliferation 378
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 374
Aberrant crypt foci in patients with colorectal cancer 373
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 373
The cause of colorectal cancer 369
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 369
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 367
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 364
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 360
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 358
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 357
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 354
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 351
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 350
Histology of aberrant crypt foci in the human colon 349
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 342
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 340
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 340
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 337
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 336
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 336
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 336
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 335
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 329
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 329
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 326
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 326
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 326
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 324
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 321
Clinical features of colorectal cancer patients in advanced age: a population-based approach 320
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 317
Microsatellite instability and colorectal cancer prognosis. 316
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 316
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 315
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 312
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. 312
Cholesterol esterase activity of human intestinal mucosa 311
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 311
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 310
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 308
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 306
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 300
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 300
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 299
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 297
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 295
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 294
Infliximab-related hepatitis: discussion of a case and review of the literature. 290
Effects of acute changes of bile acid pool composition on biliary lipid secretion 288
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 286
Alteration of drug metabolism during cholestasis in man 285
Colorectal carcinoma in different age groups: A population based investigation 284
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 284
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 284
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. 283
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 281
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 281
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 279
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 279
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 278
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 276
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 276
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 276
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 275
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 275
Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients. 274
Peutz-Jeghers syndrome: a systematic review and recommendations for management 274
Antioxidant vitamins and colorectal adenoma 272
Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel 272
Antioxidant vitamins and lactulose for the prevention of the recurrence of colorectal adenomas 272
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients] 270
Totale 34.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 326.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 326.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.775 0 0 466 488 134 285 358 273 633 392 1.072 674
2022/20235.088 686 528 321 499 628 951 66 451 608 35 189 126
2023/20243.078 120 211 186 190 799 257 298 435 81 47 98 356
2024/202511.798 445 117 146 870 2.404 1.693 767 654 1.310 708 1.238 1.446
2025/202626.768 1.449 1.011 2.235 3.595 5.892 1.675 2.785 1.323 2.027 1.827 1.718 1.231
2026/20273.001 719 1.432 850 0 0 0 0 0 0 0 0 0
Totale 82.681